# John D. Minna

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/john-d-minna/

## Facts

| Field | Value |
| --- | --- |
| Citations | 114,425 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 174 |
| i10-index | 772 |
| Last Known Institution | Southwestern Medical Center |
| OpenAlex ID | https://openalex.org/A5048865240 |
| ORCID iD | https://orcid.org/0000-0002-7776-0767 |
| Works | 2,321 |

## Researcher papers

Showing 12 of 15.

- [Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs](https://scholariq.org/papers/using-multiplexed-assays-of-oncogenic-drivers-in-lung-cancers-to-select-targeted/)
- [Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data](https://scholariq.org/papers/molecular-subtypes-of-small-cell-lung-cancer-a-synthesis-of-human-and-mouse/)
- [An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance](https://scholariq.org/papers/an-epithelial-mesenchymal-transition-gene-signature-predicts-resistance-to-egfr/)
- [Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer](https://scholariq.org/papers/comprehensive-genomic-analysis-identifies-sox2-as-a-frequently-amplified-gene-in/)
- [A small-cell lung cancer genome with complex signatures of tobacco exposure](https://scholariq.org/papers/a-small-cell-lung-cancer-genome-with-complex-signatures-of-tobacco-exposure/)
- [Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities](https://scholariq.org/papers/patterns-of-transcription-factor-programs-and-immune-pathway-activation-define/)
- [SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas](https://scholariq.org/papers/sox2-is-an-amplified-lineage-survival-oncogene-in-lung-and-esophageal-squamous/)
- [Co-occurring Genomic Alterations Define Major Subsets of <i>KRAS</i> -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities](https://scholariq.org/papers/co-occurring-genomic-alterations-define-major-subsets-of-i-kras-i-mutant-lung/)
- [Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery](https://scholariq.org/papers/molecular-profiling-of-breast-cancer-cell-lines-defines-relevant-tumor-models/)
- [Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1](https://scholariq.org/papers/proteomic-profiling-identifies-dysregulated-pathways-in-small-cell-lung-cancer/)
- [Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome](https://scholariq.org/papers/effect-of-kras-oncogene-substitutions-on-protein-behavior-implications-for/)
- [EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance](https://scholariq.org/papers/egfr-mediated-beclin-1-phosphorylation-in-autophagy-suppression-tumor/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.